x

Posted 18 October, 2023

Mirion Technologies, Inc. appointed new CEO

CEO Change detected for ticker NYSE:MIR in a 8-K filed on 18 October, 2023.


  On October 13, 2023, Mr. Michael Rossi, who has served as the Medical Group President of Mirion Technologies, Inc. (the "Company"), notified the Company of his decision to resign from his position, effective November 1, 2023, in order to assume a CEO role at another public company.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Mirion Technologies, Inc.
None • None
Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. It operates through the Medical and Technologies segments. The Medical segment consists of sales, products, and services to customers in the medical market. The Technologies segment involves nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.
Market Cap
$2.26B
View Company Details
Mirion Technologies, Inc. by TradingView
Relevant filing section
Item 5.02(b) Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On October 13, 2023, Mr. Michael Rossi, who has served as the Medical Group President of Mirion Technologies, Inc. (the "Company"), notified the Company of his decision to resign from his position, effective November 1, 2023, in order to assume a CEO role at another public company. Mr. Thomas Logan, the Company's Chief Executive Officer, will reassume the responsibilities of Medical Group President until a permanent successor is named. Mr. Logan had previously served as acting Medical Group President through much of 2022. Mr. Rossi's resignation from the Company is not due to any disagreement with the Company or any matter relating to any of the Company's operations, policies or practices.